semaglutide lizard The strange link between a venomous and modern weight-loss drugs | by Dr Chris Earl MOL-BIO Did you know that the

[10] [11] Based on data from retatrutide clinical trials (NEJM, 2023) and experience with similar approved agents, patients may experience: Redness, swelling, or itching at the injection site, which typically resolves within a few hours to days Bruising or mild pain immediately following injection Nodules or localised reactions beneath the skin, which may occur with repeated injections at the same site These reactions are generally mild and self-limiting

It is often started at a low dose and gradually increased for better tolerance

When limited to only studies with good methodological quality, all outcomes remained statistically significant except for LDL-C, HbA1c and TG

Safety/efficacy may differ in non-approved populations